SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+24.18%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$840M
AUM Growth
+$840M
(+39%)
Cap. Flow
+$94.3M
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
49.44%
Holding
116
New
35
Increased
16
Reduced
23
Closed
30
Top Buys
| 1 |
AbbVie
ABBV
|
$55.9M |
| 2 |
Nice
NICE
|
$24.5M |
| 3 |
Amgen
AMGN
|
$18.9M |
| 4 |
AstraZeneca
AZN
|
$16.9M |
| 5 |
Eli Lilly
LLY
|
$14.8M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$35.5M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$22.4M |
| 3 |
Sarepta Therapeutics
SRPT
|
$21.6M |
| 4 |
Pfizer
PFE
|
$18M |
| 5 |
Novo Nordisk
NVO
|
$11.5M |
Sector Composition
| 1 | Healthcare | 81.38% |
| 2 | Technology | 10.39% |
| 3 | Consumer Discretionary | 2.06% |
| 4 | Industrials | 1.78% |
| 5 | Communication Services | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kornit Digital
KRNT
$669M
| $9.42M | 0.89% | +176,507 | New | +$9.42M |
|
27
Passage Bio
PASG
$22.7M
| $9.41M | 0.89% | 344,439 -133,732 | -28% | -$3.66M |
|
28
Fiserv
FI
$75.1B
| $9.3M | 0.87% | +95,246 | New | +$9.3M |
|
29
Kura Oncology
KURA
$686M
| $8.71M | 0.82% | +534,494 | New | +$8.71M |
|
|
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.22M | 0.77% | +72,000 | New | +$8.22M |
|
|
SIOX
31
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $8.06M | 0.76% | 2,857,998 -73,020 | -2% | -$206K |
|
32
Fate Therapeutics
FATE
$120M
| $7.72M | 0.73% | +225,000 | New | +$7.72M |
|
33
Repare Therapeutics
RPTX
$71.7M
| $7.6M | 0.71% | +245,000 | New | +$7.6M |
|
34
Karyopharm Therapeutics
KPTI
$61.7M
| $7.44M | 0.7% | 392,831 -157,169 | -29% | -$2.98M |
|
35
Teva Pharmaceuticals
TEVA
$21.1B
| $7.19M | 0.68% | 582,878 +226,165 | +63% | +$2.79M |
|
36
Rocket Pharmaceuticals
RCKT
$354M
| $7.12M | 0.67% | 340,016 +5,000 | +1% | +$105K |
|
|
CNCE
37
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.97M | 0.66% | 700,710 -312,329 | -31% | -$3.11M |
|
38
Palo Alto Networks
PANW
$127B
| $6.89M | 0.65% | 30,000 +13,548 | +82% | +$3.11M |
|
39
SolarEdge
SEDG
$2.01B
| $6.39M | 0.6% | +46,017 | New | +$6.39M |
|
40
Aprea Therapeutics
APRE
$9.09M
| $6.14M | 0.58% | +158,289 | New | +$6.14M |
|
41
Krystal Biotech
KRYS
$4.27B
| $5.99M | 0.56% | +144,573 | New | +$5.99M |
|
42
ADMA Biologics
ADMA
$4.12B
| $5.82M | 0.55% | 1,984,949 +146,849 | +8% | +$430K |
|
43
Dover
DOV
$24.5B
| $5.56M | 0.52% | +57,576 | New | +$5.56M |
|
44
Domino's
DPZ
$15.6B
| $5.37M | 0.5% | +14,521 | New | +$5.37M |
|
45
X4 Pharmaceuticals
XFOR
$84.2M
| $5.27M | 0.5% | 565,804 -307,411 | -35% | -$2.86M |
|
46
Travere Therapeutics
TVTX
$1.56B
| $5.1M | 0.48% | +250,000 | New | +$5.1M |
|
|
47
Larimar Therapeutics
LRMR
$310M
| $5.1M | 0.48% | 396,787 -2,764,775 | -87% | -$35.5M |
|
48
Ascendis Pharma
ASND
$11.8B
| $5.08M | 0.48% | 34,373 +1,800 | +6% | +$266K |
|
49
uniQure
QURE
$896M
| $4.96M | 0.47% | 110,000 -91,107 | -45% | -$4.11M |
|
50
Exicure
XCUR
$35.4M
| $4.64M | 0.44% | 1,900,000 -1,384,795 | -42% | -$3.38M |
|